Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould lowered the price target on Bristol-Myers Squibb Co ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




